Related Experiment Video
Updated: Jun 16, 2026

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment
Published on: January 7, 2015
Enfortumab Vedotin-Related Skin Toxicities: Insights From Clinical and Histopathological Analysis
Yuki Kuma1, Makiko Kido-Nakahara1, Yoko Kuba-Fuyuno1
1Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
None:
Enfortumab vedotin (EV), targeting Nectin-4, is effective in advanced urothelial carcinoma but frequently causes skin toxicities. This study examined the possible contribution of prior immune checkpoint inhibitor (ICI) therapy and higher EV doses to EV-related skin toxicity (EVST) development. Histopathological findings suggested both direct keratinocyte damage and immune-mediated mechanisms. These insights may improve clinical management of EVST.
More Related Videos
08:52Intravital Microscopy of Tumor-associated Vasculature Using Advanced Dorsal Skinfold Window Chambers on Transgenic Fluorescent Mice
Published on: January 19, 2018
12:41Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis
Published on: December 23, 2022
Related Concept Videos
Drug Toxicity: Overview
Drug Toxicity: Risk factors
Drug Toxicity: Allergic Reactions
Bioactivation and Tissue Toxicity
Cytotoxic Edema: Pathophysiology